UM

Browse/Search Results:  1-10 of 48 Help

Selected(0)Clear Items/Page:    Sort:
Saving the Old Regime with New Elites? Co-opting Foreign-Educated Returnee Elites, Local Council Elections, and Popular Revolts in Late Qing China, 1901–1911 Conference paper
Chu Lin, Wei Sun, WANG CHENGLI. Saving the Old Regime with New Elites? Co-opting Foreign-Educated Returnee Elites, Local Council Elections, and Popular Revolts in Late Qing China, 1901–1911[C], 2024.
Authors:  Chu Lin;  Wei Sun;  WANG CHENGLI
Favorite |  | Submit date:2024/08/26
An Hsp70 promoter–based mouse for heat shock–induced gene modulation Journal article
Chen, Hangang, Xie, Yangli, Zhang, Mei, Huang, Junlan, Jiang, Wanling, Zhang, Ruobin, Li, Can, Du, Xiaolan, Chen, Hua, Nie, Qiang, Liang, Sen, Tan, Qiaoyan, Yang, Jing, Jin, Min, Huang, Shuo, Kuang, Liang, Su, Nan, Qi, Huabing, Luo, Xiaoqing, Xu, Xiaoling, Deng, Chuxia, Chen, Lin, Luo, Fengtao. An Hsp70 promoter–based mouse for heat shock–induced gene modulation[J]. Journal of Molecular Medicine, 2024, 102(5), 693-707.
Authors:  Chen, Hangang;  Xie, Yangli;  Zhang, Mei;  Huang, Junlan;  Jiang, Wanling; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:4.8/4.7 | Submit date:2024/05/16
Cre/loxp System  Gene Modulation  Heat Shock  Hsp70 Promoter  Mouse Model  
Standard: Human intestinal cancer organoids Other
2023-12-01
Authors:  Hanqing Lin1;  Yalong Wang;  Chunyan Cheng;  Yuxin Qian;  Jie Hao; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1 | Submit date:2023/08/03
BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance Journal article
Xiaodong Shu, Jianjie Li, Un In Chan, Sek Man Su, Changxiang Shi, Xin Zhang, Tingting An, Jun Xu, Lihua Mo, Jianlin Liu, Yuqing Wang, Xiaoling Li, Min Deng, Josh Haipeng Lei, Chunfei Wang, Hao Tian, Sun Heng, Joong Sup Shim, Xuanjun Zhang, Yunlu Dai, Zhicheng Yao, Xiaying Kuang, Ying Lin, Chu-Xia Deng, Xiaoling Xu. BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance[J]. CANCER RESEARCH, 2023, 83(15), 2614-2633.
Authors:  Xiaodong Shu;  Jianjie Li;  Un In Chan;  Sek Man Su;  Changxiang Shi; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:12.5/11.6 | Submit date:2023/08/30
Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation Journal article
Zhou,Jing Bo, Tang,Dongyang, He,Lin, Lin,Shiqi, Lei,Josh Haipeng, Sun,Heng, Xu,Xiaoling, Deng,Chu Xia. Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation[J]. Pharmacological Research, 2023, 194, 106830.
Authors:  Zhou,Jing Bo;  Tang,Dongyang;  He,Lin;  Lin,Shiqi;  Lei,Josh Haipeng; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:9.1/9.0 | Submit date:2023/08/03
Bortezomib (Pubchem Cid: 387447)  Cepharanthine (Pubchem Cid: 10206)  Docetaxel (Taxotere) (Pubchem Cid: 11970251)  Drug Combination Therapy  Flunarizine Dihydrochloride (Pubchem Cid: 5282407)  Lapatinib Ditosylate (Pubchem Cid: 9941095)  Machine Learning  Pazopanib Hydrochloride (Pubchem Cid: 11525740)  Potential Combination Biomarkers  Tamoxifen Citrate (Pubchem Cid: 2733525)  Three-dimensional Tumor Slice Culture  Vatalanib (Pubchem Cid: 151194)  Vincristine (Pubchem Cid: 5978)  Xl-184 (Cabozantinib) (Pubchem Cid: 25102847)  
Standard: Human intestinal organoids Other
2023-06-14
Authors:  Yalong Wang;  Hanqing Lin;  Lianzheng Zhao;  Fan Hong;  Jie Hao; et al.
Favorite | TC[WOS]:3 TC[Scopus]:5 | Submit date:2023/08/03
Recent advances in organotypic tissue slice cultures for anticancer drug development Review article
2022
Authors:  He, Lin;  Deng, Chuxia
Favorite | TC[WOS]:16 TC[Scopus]:17  IF:8.2/8.3 | Submit date:2023/01/30
Anticancer Drug Discovery  Individualized Treatment  Organotypic Tissue Slice Culture  Precision Oncology  
Novel treatment for refractory rheumatoid arthritis with total glucosides of paeony and nobiletin codelivered in a self-nanoemulsifying drug delivery system Journal article
Qu, Biao, Wang, Xiao lin, Zheng, De chong, Mai, Chu tian, Liu, Zhong qiu, Zhou, Hua, Xie, Ying. Novel treatment for refractory rheumatoid arthritis with total glucosides of paeony and nobiletin codelivered in a self-nanoemulsifying drug delivery system[J]. Acta Pharmacologica Sinica, 2022, 43(8), 2094-2108.
Authors:  Qu, Biao;  Wang, Xiao lin;  Zheng, De chong;  Mai, Chu tian;  Liu, Zhong qiu; et al.
Favorite | TC[WOS]:11 TC[Scopus]:10  IF:6.9/7.6 | Submit date:2023/01/30
Nobiletin  P-glycoprotein  Refractory Rheumatoid Arthritis  Self-nanoemulsifying Drug Delivery Systems  Total Glucosides Of Paeony  
Expansion of FGFR3-positive nucleus pulposus cells plays important roles in postnatal nucleus pulposus growth and regeneration Journal article
Xu, Meng, Huang, Junlan, Jin, Min, Jiang, Wanling, Luo, Fengtao, Tan, Qiaoyan, Zhang, Ruobin, Luo, Xiaoqing, Kuang, Liang, Zhang, Dali, Liang, Sen, Qi, Huabing, Chen, Hangang, Ni, Zhenhong, Su, Nan, Yang, Jing, Du, Xiaolan, Chen, Bo, Deng, Chuxia, Xie, Yangli, Chen, Lin. Expansion of FGFR3-positive nucleus pulposus cells plays important roles in postnatal nucleus pulposus growth and regeneration[J]. Stem Cell Research & Therapy, 2022, 13, 227.
Authors:  Xu, Meng;  Huang, Junlan;  Jin, Min;  Jiang, Wanling;  Luo, Fengtao; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:7.1/7.9 | Submit date:2022/08/02
Intervertebral Disc Degeneration  Nucleus Pulposus  Cell Proliferation  Fgfr3  Genetic Mouse Models  
FGFR2–BRD4 Axis Regulates Transcriptional Networks of Histone 3 Modification and Synergy Between Its Inhibitors and PD-1/PD-L1 in a TNBC Mouse Model Journal article
Lei, Josh Haipeng, Zhang, Lei, Wang, Zhenyi, Peltier, Raoul, Xie, Yusheng, Chen, Ganchao, Lin, Shiqi, Miao, Kai, Deng, Chu Xia, Sun, Hongyan. FGFR2–BRD4 Axis Regulates Transcriptional Networks of Histone 3 Modification and Synergy Between Its Inhibitors and PD-1/PD-L1 in a TNBC Mouse Model[J]. Frontiers in Immunology, 2022, 13, 861221.
Authors:  Lei, Josh Haipeng;  Zhang, Lei;  Wang, Zhenyi;  Peltier, Raoul;  Xie, Yusheng; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:5.7/6.8 | Submit date:2022/05/31
Brd4  Epigenetic  Fgfr2  Immunotherapy  Posttranslational Modifications  Tnbc